Select Publications
Books
2018, The Diversity of Layered Halide Perovskites, http://dx.doi.org/10.1146/annurev-matsci-070317-124406
,2017, Asthma first aid management in schools, Gray M; Burns C; Jaffe A, (eds.), Apple iTunes Store
,2006, Cystic Fibrosis in the 21st Century, Bush A; Alton EWFW; Davies JC; Griesenbach U; Jaffe A, (eds.), Karger Medical and Scientific Publishers
,Book Chapters
2024, 'Macrolides and Cystic Fibrosis', in Progress in Inflammation Research, pp. 59 - 92, http://dx.doi.org/10.1007/978-3-031-42859-3_4
,2021, 'Detection and management of early glucose abnormalities in cystic fibrosis', in Cystic Fibrosis - Facts, Management and Advances, IntechOpen, http://dx.doi.org/10.5772/intechopen.92847
,2021, 'Pleural Effusion, Necrotizing Pneumonia and Long-Term Morbidity of Respiratory Infection in Childhood', in Encyclopedia of Respiratory Medicine, Second Edition, pp. 132 - 145, http://dx.doi.org/10.1016/B978-0-08-102723-3.00025-1
,2019, 'Diseases of the pleural space', in Wimott RW; Deterding R; Li A; Ratjen F; Sly P; Zar HH; Bush A (ed.), Kendig's Disorders of the Respiratory Tract in Children, Elsevier
,2018, 'Cystic Fibrosis', in Rudolph's Pediatrics, 23rd Edition, McGraw-Hill Education / Medical, https://accesspediatrics.mhmedical.com/content.aspx?bookid=2126§ionid=190246234
,2018, '69 - Air and Fluid in the Pleural Space', in Kendig's Disorders of the Respiratory Tract in Children, pp. 1007 - 1026.e3, http://dx.doi.org/10.1016/B978-0-323-44887-1.00069-9
,2016, 'Anti-asthma Drugs, Overview', in Compendium of Inflammatory Diseases, Springer Basel, pp. 64 - 69, http://dx.doi.org/10.1007/978-3-7643-8550-7_6
,2016, 'Antimuscarinics', in Compendium of Inflammatory Diseases, Springer Basel, pp. 101 - 105, http://dx.doi.org/10.1007/978-3-7643-8550-7_49
,2016, 'Beta2 Receptor Agonists', in Compendium of Inflammatory Diseases, Springer Basel, pp. 210 - 214, http://dx.doi.org/10.1007/978-3-7643-8550-7_17
,2016, 'Beta2 Receptor Agonists', in Encyclopedia of Inflammatory Diseases, Springer Basel, pp. 1 - 6, http://dx.doi.org/10.1007/978-3-0348-0620-6_17-2
,2016, 'Chromones: Cromoglycate and Nedocromil', in Compendium of Inflammatory Diseases, Springer Basel, pp. 330 - 332, http://dx.doi.org/10.1007/978-3-7643-8550-7_63
,2016, 'Theophylline', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1252 - 1254, http://dx.doi.org/10.1007/978-3-7643-8550-7_53
,2015, 'Anti-asthma drugs, overview', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_6-1
,2015, 'Anti-muscurinics', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_49-1
,2015, 'Beta₂ agonists', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_17-1
,2015, 'Chromones - Cromoglycate and nedocromil', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_63-1
,2015, 'Theophylline', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_53-1
,2012, 'Asthma', in South M; Isaacs D (ed.), Practical Paediatrics, Elsevier, London, pp. 482 - 490
,2009, 'Primary ciliary dyskinesia', in Haver K; Brigger MT; Hardy SC; Hartnick CJ (ed.), Pediatric Aerodigestive Disorders, Pleural Publishing Inc, San Diego, pp. 353 - 376
,2008, 'Assessment, definition and treatment of hypoxia in children`s with cystic fibrosis', in Yearbook Respiratory Care Clinics and Applied Technologies, World Federation of Respiratory Care and Applied Technologies, pp. 769 - 773
,2008, 'Management techniques in childhood empyema', in Yearbook Respiratory Care Clinics and Applied Technologies, World Federation of Respiratory Care and Applied Technologies, pp. 439 - 442
,2007, 'ADHD and sleep disorders', in Taylor E (ed.), People with Hyperactivity Understanding and Managing Their Problems, Mac Keith Press, pp. 160 - 169
,2007, 'Basic science - what will it deliver: non gene therapy treatments', in Hodson ME; Geddes D; Bush A (ed.), Cystic Fibrosis, Hodder Arnold, pp. 463 - 469
,2005, 'Macrolides in cystic fibrosis', in Rubin BK; Tamaoki J (ed.), Antibiotics as anti-inflammatory and immunomodulatory agents, Birkhauser Publishing, Basel
,2005, 'Non-invasive measurements of inflammation in asthma', in Dinwiddie R; Brand PLP (ed.), Paediatric Asthma and Allergy, Quay Books, Wiltshire, United Kingdom
,2005, 'The Future', in Cystic Fibrosis in the 21st Century, KARGER, pp. 316 - 322, http://dx.doi.org/10.1159/000088618
,2003, 'Cystic Fibrosis', in Medicines for Children
,Journal articles
2024, 'Risk Factors and Clinical Prognosis Associated With RSV-ALRI Intensive Care Unit Admission in Children <2 Years of Age: A Multicenter Study.', Pediatr Infect Dis J, http://dx.doi.org/10.1097/INF.0000000000004288
,2024, 'Asthma-community acquired pneumonia co-diagnosis in children: a scoping review', Journal of Asthma, 61, pp. 282 - 291, http://dx.doi.org/10.1080/02770903.2023.2280843
,2023, 'BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis', Trials, 24, http://dx.doi.org/10.1186/s13063-023-07076-8
,2023, 'Automated detection of airflow obstructive diseases: A systematic review of the last decade (2013-2022)', Computer Methods and Programs in Biomedicine, 241, http://dx.doi.org/10.1016/j.cmpb.2023.107746
,2023, 'Erratum to “Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study” [Vaccine 41(1) (2023) 85–91, (S0264410X22013822), (10.1016/j.vaccine.2022.11.006)]', Vaccine, 41, pp. 6401 - 6402, http://dx.doi.org/10.1016/j.vaccine.2023.07.039
,2023, 'Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa', BMJ Open Respiratory Research, 10, http://dx.doi.org/10.1136/bmjresp-2022-001360
,2023, 'Clinical outcomes of adults and children with cystic fibrosis during the COVID-19 pandemic', Journal of Cystic Fibrosis, 22, pp. 581 - 586, http://dx.doi.org/10.1016/j.jcf.2022.09.006
,2023, 'Comparing Cytology Brushes for Optimal Human Nasal Epithelial Cell Collection: Implications for Airway Disease Diagnosis and Research', Journal of Personalized Medicine, 13, pp. 864, http://dx.doi.org/10.3390/jpm13050864
,2023, 'Molecular and Functional Characteristics of Airway Epithelium under Chronic Hypoxia', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms24076475
,2023, 'Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants', Pediatric Pulmonology, 58, pp. 1210 - 1220, http://dx.doi.org/10.1002/ppul.26324
,2023, 'Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare', American Journal of Human Genetics, 110, pp. 419 - 426, http://dx.doi.org/10.1016/j.ajhg.2023.01.018
,2023, 'Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study', Vaccine, 41, pp. 85 - 91, http://dx.doi.org/10.1016/j.vaccine.2022.11.006
,2023, 'Asthma and Susceptibility to COVID-19 in Australian Children During Alpha, Delta and Omicron Waves of the COVID-19 Pandemic', Journal of Asthma and Allergy, 16, pp. 1139 - 1155, http://dx.doi.org/10.2147/JAA.S421158
,2023, 'Corrigendum to: Asthma and Susceptibility to COVID-19 in Australian Children During Alpha, Delta and Omicron Waves of the COVID-19 Pandemic (J Asthma Allergy. 2023;16:1139–1155)', Journal of Asthma and Allergy, 16, pp. 1195 - 1196, http://dx.doi.org/10.2147/JAA.S446596
,2023, 'Diet and the gut-lung axis in cystic fibrosis–direct & indirect links', Gut Microbes, 15, http://dx.doi.org/10.1080/19490976.2022.2156254
,2023, 'Learning to make a difference for chILD: Value creation through network collaboration and team science', Pediatric Pulmonology, http://dx.doi.org/10.1002/ppul.26377
,2023, 'Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient', Frontiers in Molecular Biosciences, 10, http://dx.doi.org/10.3389/fmolb.2023.1148501
,2023, 'Rare diseases: New approaches to diagnosis and care', Medicine Today, 24, pp. 69 - 76
,2023, 'Saline at lower tonicity in cystic fibrosis (SALTI-CF) trial comparing 0.9% versus 3% versus 6% nebulised saline', European Respiratory Journal, 62, http://dx.doi.org/10.1183/13993003.00960-2021
,2023, 'Screening for Cystic Fibrosis Related Complications in the Context of a Pandemic and Altered Models of Care', Health Services Insights, 16, http://dx.doi.org/10.1177/11786329231205145
,